[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

CRM197 Market, Global Outlook and Forecast 2022-2028

May 2022 | 62 pages | ID: C58B58F26A9DEN
Market Monitor Global

US$ 3,250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
CRM197 is a non-toxic mutant of diphtheria toxin and it's widely used as a carrier protein for conjugate vaccines.

This report contains market size and forecasts of CRM197 in Global, including the following market information:

Global CRM197 Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global CRM197 market was valued at 177.2 million in 2021 and is projected to reach US$ 249.9 million by 2028, at a CAGR of 5.0% during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Research Grade CRM197 Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of CRM197 include Pfizer Inc., Ligand Pharmaceuticals, CanSino Biologic, Beijing Kexing Biology Product, Scarab Genomics, Xpress Biologics, Fina Biosolutions, Eubiologics and EirGenix Inc.. etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the CRM197 companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global CRM197 Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global CRM197 Market Segment Percentages, by Type, 2021 (%)
  • Research Grade CRM197
  • cGMP Grade CRM197
Global CRM197 Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global CRM197 Market Segment Percentages, by Application, 2021 (%)
  • Pneumococcal Conjugate Vaccine
  • Meningococcal Polysaccharide Conjugate Vaccine
  • Others
Global CRM197 Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global CRM197 Market Segment Percentages, By Region and Country, 2021 (%)
  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Nordic Countries
    • Benelux
    • Rest of Europe
  • Asia
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Rest of Asia
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • Turkey
    • Israel
    • Saudi Arabia
    • UAE
    • Rest of Middle East & Africa
Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies CRM197 revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies CRM197 revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:
  • Pfizer Inc.
  • Ligand Pharmaceuticals
  • CanSino Biologic
  • Beijing Kexing Biology Product
  • Scarab Genomics
  • Xpress Biologics
  • Fina Biosolutions
  • Eubiologics
  • EirGenix Inc.
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 CRM197 Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global CRM197 Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL CRM197 OVERALL MARKET SIZE

2.1 Global CRM197 Market Size: 2021 VS 2028
2.2 Global CRM197 Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top CRM197 Players in Global Market
3.2 Top Global CRM197 Companies Ranked by Revenue
3.3 Global CRM197 Revenue by Companies
3.4 Top 3 and Top 5 CRM197 Companies in Global Market, by Revenue in 2021
3.5 Global Companies CRM197 Product Type
3.6 Tier 1, Tier 2 and Tier 3 CRM197 Players in Global Market
  3.6.1 List of Global Tier 1 CRM197 Companies
  3.6.2 List of Global Tier 2 and Tier 3 CRM197 Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global CRM197 Market Size Markets, 2021 & 2028
  4.1.2 Research Grade CRM197
  4.1.3 cGMP Grade CRM197
4.2 By Type - Global CRM197 Revenue & Forecasts
  4.2.1 By Type - Global CRM197 Revenue, 2017-2022
  4.2.2 By Type - Global CRM197 Revenue, 2023-2028
  4.2.3 By Type - Global CRM197 Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global CRM197 Market Size, 2021 & 2028
  5.1.2 Pneumococcal Conjugate Vaccine
  5.1.3 Meningococcal Polysaccharide Conjugate Vaccine
  5.1.4 Others
5.2 By Application - Global CRM197 Revenue & Forecasts
  5.2.1 By Application - Global CRM197 Revenue, 2017-2022
  5.2.2 By Application - Global CRM197 Revenue, 2023-2028
  5.2.3 By Application - Global CRM197 Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global CRM197 Market Size, 2021 & 2028
6.2 By Region - Global CRM197 Revenue & Forecasts
  6.2.1 By Region - Global CRM197 Revenue, 2017-2022
  6.2.2 By Region - Global CRM197 Revenue, 2023-2028
  6.2.3 By Region - Global CRM197 Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America CRM197 Revenue, 2017-2028
  6.3.2 US CRM197 Market Size, 2017-2028
  6.3.3 Canada CRM197 Market Size, 2017-2028
  6.3.4 Mexico CRM197 Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe CRM197 Revenue, 2017-2028
  6.4.2 Germany CRM197 Market Size, 2017-2028
  6.4.3 France CRM197 Market Size, 2017-2028
  6.4.4 U.K. CRM197 Market Size, 2017-2028
  6.4.5 Italy CRM197 Market Size, 2017-2028
  6.4.6 Russia CRM197 Market Size, 2017-2028
  6.4.7 Nordic Countries CRM197 Market Size, 2017-2028
  6.4.8 Benelux CRM197 Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia CRM197 Revenue, 2017-2028
  6.5.2 China CRM197 Market Size, 2017-2028
  6.5.3 Japan CRM197 Market Size, 2017-2028
  6.5.4 South Korea CRM197 Market Size, 2017-2028
  6.5.5 Southeast Asia CRM197 Market Size, 2017-2028
  6.5.6 India CRM197 Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America CRM197 Revenue, 2017-2028
  6.6.2 Brazil CRM197 Market Size, 2017-2028
  6.6.3 Argentina CRM197 Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa CRM197 Revenue, 2017-2028
  6.7.2 Turkey CRM197 Market Size, 2017-2028
  6.7.3 Israel CRM197 Market Size, 2017-2028
  6.7.4 Saudi Arabia CRM197 Market Size, 2017-2028
  6.7.5 UAE CRM197 Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Pfizer Inc.
  7.1.1 Pfizer Inc. Corporate Summary
  7.1.2 Pfizer Inc. Business Overview
  7.1.3 Pfizer Inc. CRM197 Major Product Offerings
  7.1.4 Pfizer Inc. CRM197 Revenue in Global Market (2017-2022)
  7.1.5 Pfizer Inc. Key News
7.2 Ligand Pharmaceuticals
  7.2.1 Ligand Pharmaceuticals Corporate Summary
  7.2.2 Ligand Pharmaceuticals Business Overview
  7.2.3 Ligand Pharmaceuticals CRM197 Major Product Offerings
  7.2.4 Ligand Pharmaceuticals CRM197 Revenue in Global Market (2017-2022)
  7.2.5 Ligand Pharmaceuticals Key News
7.3 CanSino Biologic
  7.3.1 CanSino Biologic Corporate Summary
  7.3.2 CanSino Biologic Business Overview
  7.3.3 CanSino Biologic CRM197 Major Product Offerings
  7.3.4 CanSino Biologic CRM197 Revenue in Global Market (2017-2022)
  7.3.5 CanSino Biologic Key News
7.4 Beijing Kexing Biology Product
  7.4.1 Beijing Kexing Biology Product Corporate Summary
  7.4.2 Beijing Kexing Biology Product Business Overview
  7.4.3 Beijing Kexing Biology Product CRM197 Major Product Offerings
  7.4.4 Beijing Kexing Biology Product CRM197 Revenue in Global Market (2017-2022)
  7.4.5 Beijing Kexing Biology Product Key News
7.5 Scarab Genomics
  7.5.1 Scarab Genomics Corporate Summary
  7.5.2 Scarab Genomics Business Overview
  7.5.3 Scarab Genomics CRM197 Major Product Offerings
  7.5.4 Scarab Genomics CRM197 Revenue in Global Market (2017-2022)
  7.5.5 Scarab Genomics Key News
7.6 Xpress Biologics
  7.6.1 Xpress Biologics Corporate Summary
  7.6.2 Xpress Biologics Business Overview
  7.6.3 Xpress Biologics CRM197 Major Product Offerings
  7.6.4 Xpress Biologics CRM197 Revenue in Global Market (2017-2022)
  7.6.5 Xpress Biologics Key News
7.7 Fina Biosolutions
  7.7.1 Fina Biosolutions Corporate Summary
  7.7.2 Fina Biosolutions Business Overview
  7.7.3 Fina Biosolutions CRM197 Major Product Offerings
  7.7.4 Fina Biosolutions CRM197 Revenue in Global Market (2017-2022)
  7.7.5 Fina Biosolutions Key News
7.8 Eubiologics
  7.8.1 Eubiologics Corporate Summary
  7.8.2 Eubiologics Business Overview
  7.8.3 Eubiologics CRM197 Major Product Offerings
  7.8.4 Eubiologics CRM197 Revenue in Global Market (2017-2022)
  7.8.5 Eubiologics Key News
7.9 EirGenix Inc.
  7.9.1 EirGenix Inc. Corporate Summary
  7.9.2 EirGenix Inc. Business Overview
  7.9.3 EirGenix Inc. CRM197 Major Product Offerings
  7.9.4 EirGenix Inc. CRM197 Revenue in Global Market (2017-2022)
  7.9.5 EirGenix Inc. Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

LIST OF TABLES

Table 1. CRM197 Market Opportunities & Trends in Global Market
Table 2. CRM197 Market Drivers in Global Market
Table 3. CRM197 Market Restraints in Global Market
Table 4. Key Players of CRM197 in Global Market
Table 5. Top CRM197 Players in Global Market, Ranking by Revenue (2021)
Table 6. Global CRM197 Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global CRM197 Revenue Share by Companies, 2017-2022
Table 8. Global Companies CRM197 Product Type
Table 9. List of Global Tier 1 CRM197 Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 CRM197 Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global CRM197 Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - CRM197 Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - CRM197 Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global CRM197 Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - CRM197 Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - CRM197 Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global CRM197 Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global CRM197 Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global CRM197 Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America CRM197 Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America CRM197 Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe CRM197 Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe CRM197 Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia CRM197 Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia CRM197 Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America CRM197 Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America CRM197 Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa CRM197 Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa CRM197 Revenue, (US$, Mn), 2023-2028
Table 30. Pfizer Inc. Corporate Summary
Table 31. Pfizer Inc. CRM197 Product Offerings
Table 32. Pfizer Inc. CRM197 Revenue (US$, Mn), (2017-2022)
Table 33. Ligand Pharmaceuticals Corporate Summary
Table 34. Ligand Pharmaceuticals CRM197 Product Offerings
Table 35. Ligand Pharmaceuticals CRM197 Revenue (US$, Mn), (2017-2022)
Table 36. CanSino Biologic Corporate Summary
Table 37. CanSino Biologic CRM197 Product Offerings
Table 38. CanSino Biologic CRM197 Revenue (US$, Mn), (2017-2022)
Table 39. Beijing Kexing Biology Product Corporate Summary
Table 40. Beijing Kexing Biology Product CRM197 Product Offerings
Table 41. Beijing Kexing Biology Product CRM197 Revenue (US$, Mn), (2017-2022)
Table 42. Scarab Genomics Corporate Summary
Table 43. Scarab Genomics CRM197 Product Offerings
Table 44. Scarab Genomics CRM197 Revenue (US$, Mn), (2017-2022)
Table 45. Xpress Biologics Corporate Summary
Table 46. Xpress Biologics CRM197 Product Offerings
Table 47. Xpress Biologics CRM197 Revenue (US$, Mn), (2017-2022)
Table 48. Fina Biosolutions Corporate Summary
Table 49. Fina Biosolutions CRM197 Product Offerings
Table 50. Fina Biosolutions CRM197 Revenue (US$, Mn), (2017-2022)
Table 51. Eubiologics Corporate Summary
Table 52. Eubiologics CRM197 Product Offerings
Table 53. Eubiologics CRM197 Revenue (US$, Mn), (2017-2022)
Table 54. EirGenix Inc. Corporate Summary
Table 55. EirGenix Inc. CRM197 Product Offerings
Table 56. EirGenix Inc. CRM197 Revenue (US$, Mn), (2017-2022)

LIST OF FIGURES

Figure 1. CRM197 Segment by Type in 2021
Figure 2. CRM197 Segment by Application in 2021
Figure 3. Global CRM197 Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global CRM197 Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global CRM197 Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by CRM197 Revenue in 2021
Figure 8. By Type - Global CRM197 Revenue Market Share, 2017-2028
Figure 9. By Application - Global CRM197 Revenue Market Share, 2017-2028
Figure 10. By Region - Global CRM197 Revenue Market Share, 2017-2028
Figure 11. By Country - North America CRM197 Revenue Market Share, 2017-2028
Figure 12. US CRM197 Revenue, (US$, Mn), 2017-2028
Figure 13. Canada CRM197 Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico CRM197 Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe CRM197 Revenue Market Share, 2017-2028
Figure 16. Germany CRM197 Revenue, (US$, Mn), 2017-2028
Figure 17. France CRM197 Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. CRM197 Revenue, (US$, Mn), 2017-2028
Figure 19. Italy CRM197 Revenue, (US$, Mn), 2017-2028
Figure 20. Russia CRM197 Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries CRM197 Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux CRM197 Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia CRM197 Revenue Market Share, 2017-2028
Figure 24. China CRM197 Revenue, (US$, Mn), 2017-2028
Figure 25. Japan CRM197 Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea CRM197 Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia CRM197 Revenue, (US$, Mn), 2017-2028
Figure 28. India CRM197 Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America CRM197 Revenue Market Share, 2017-2028
Figure 30. Brazil CRM197 Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina CRM197 Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa CRM197 Revenue Market Share, 2017-2028
Figure 33. Turkey CRM197 Revenue, (US$, Mn), 2017-2028
Figure 34. Israel CRM197 Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia CRM197 Revenue, (US$, Mn), 2017-2028
Figure 36. UAE CRM197 Revenue, (US$, Mn), 2017-2028
Figure 37. Pfizer Inc. CRM197 Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Ligand Pharmaceuticals CRM197 Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. CanSino Biologic CRM197 Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Beijing Kexing Biology Product CRM197 Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Scarab Genomics CRM197 Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Xpress Biologics CRM197 Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Fina Biosolutions CRM197 Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Eubiologics CRM197 Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. EirGenix Inc. CRM197 Revenue Year Over Year Growth (US$, Mn) & (2017-2022)



More Publications